Health
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial – The Lancet
CoronaVac was well tolerated and safe and induced humoral responses in children andadolescents aged 3–17 years. Neutralising…
We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site.Copyright © 2021 Elsevier Inc. except certain content provided by third parties. The…
Continue Reading
-
Noosa News18 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News19 hours agoMotorcyclist dies in crash with truck
-
Noosa News20 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
Business24 hours ago5 things to watch on the ASX 200 on Thursday 20 November 2025